~~<i id='469972085D'><strike id='469972085D'><tt id='469972085D'><pre id='469972085D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：focus 2025-09-07 11:15:35 - browse：171

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Republicans love RFK Jr. What's that tell us about health in 2024?

focus

hotspot

entertainment

leisure time

entertainment

JohnMoore/GettyImages“Howhastheclinicalworkyoudoaffectedyoupersonally?”We’dcometotheQ&Apartofthe

WSS

Cytokinetics CEO stresses company can launch heart drug on its own

Abortion policy in the spotlight at Republican debate

Anxious about a speech? A startup wants you to pop a minty cardiac drug

How the first Native Hawaiian psychiatrist helped diversify medicine

Republicans love RFK Jr. What's that tell us about health in 2024?

California store owner shot dead in dispute over displaying Pride flag: Police

leisure time

knowledge

focus

The high cost of giving birth even with insurance

Intellia plays down concerns on accidental germline transmission

Drug repurposing or repositioning? The language matters

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Wildfire smoke exposes gaps in outdoor worker protections

Military medical care influenced by rank and race, new study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Medical leaders decry Supreme Court decision on affirmative action

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

hotspot

Criminal prosecution for violating HIPAA: an emerging threat

CDC says it’s too soon to assess risk posed by Covid subvariant

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Arc Institute generative AI designs new CRISPR systems

National associations that represent hospice owe an apology

Vivek Ramaswamy made waves in the debate, much as in biotech

entertainment

leisure time

leisure time

entertainment